Smith & Nephew PLC (LSE:SN.) - Share price - Overview

Stock Report

Smith & Nephew PLC SN.

Last Price
GBX1,379.50

Day Change
14.50|1.06%

As of 26/04/2018
18:41:34 BST | GBX
Minimum 15 Minutes Delay.

Last Close1,365.00p
Day Range1,370.50 - 1,390.00
Mkt Cap11.94Bil
52-Wk Range1,173.00 - 1,442.00
Yield %0.00
ISINGB0009223206
Volume2,335,660
P/E1,572.98
P/S2.53
P/CF11.07

Share Price

Total Returns 25/04/2018

 Chg (%)  
More ...
Smith & Nephew PLC6.33 
FTSE 100 TR GBP8.22
 
Financials
201520162017
More ...
Income Statement
Turnover4,634.004,669.004,765.00
Operating Profit628.00801.00934.00
Net Profit410.00784.00767.00
Reported EPS0.460.880.88
Balance Sheet
Current Assets2,475.002,529.002,731.00
Non Current Assets4,692.004,815.005,135.00
Total Assets7,167.007,344.007,866.00
Current Liabilities1,344.001,348.001,346.00
Total Liabilities3,201.003,386.003,222.00
Total Equity3,966.003,958.004,644.00
Cash Flow
Operating Cash Flow1,167.00990.001,225.00
Net Change in Cash43.00-63.00113.00

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
09/03/2018Transfer inOlivier Bohuon0.0013,4970.00
09/03/2018SaleOlivier Bohuon1,325.656,36784,404.00
09/03/2018Transfer inOlivier Bohuon0.0075,5320.00
09/03/2018SaleOlivier Bohuon1,325.6535,625472,263.00

Company Profile

Smith & Nephew PLC designs, manufactures, and markets orthopedic devices and wound-care solutions. Its products include knee replacements, hip implants, nails, fixation devices, arthroscopy tools and others.

Sector

Medical Devices

Index

FTSE 100 ,FTSE 350 ,FTSE All Share ,FTSE Eurotop 300 ,FTSE techMARK Focus

Next Event 26/07/2018

Half-Yearly Results
Ratios
Comp
More ...
PER (E)21.37
Div Yld (E)0.02
PEG (E)1.03
ROCE14.43
Op Mrgn0.20
EPS Grwth0.44
Dividends
PreviousLatest
More ...
Record Date06/10/1706/04/18
Ex-Div05/10/1705/04/18
Paid01/11/1709/05/18
Amnt9.3416.27
Directors
More ...
Director and Chief Executive OfficerOlivier Bohuon
Director and Chief Financial OfficerMr. Graham Baker
Independent Non-Executive DirectorMs. Vinita Bali
Non-Executive DirectorErik Engstrom
DirectorRobin A D Freestone
Independent Non-Executive DirectorMr. Ian E. Barlow
Chairman of the BoardMr. Roberto Quarta
Independent Non-Executive DirectorMr. Joseph C. Papa
Independent Non-Executive DirectorDr. Michael A. Friedman,M.D.
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.